Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
AXDX Accelerate Diagnostics
0.961
+0.015+1.59%
Post Mkt Price
0.990
+0.029+3.05%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Assets
Current assets
Cash, cash equivalents and short term investments
-2.86% 55.39M -46.58% 36.77M -24.45% 50.38M -6.81% 63.62M
-Cash and cash equivalents
9.13% 38.99M -89.72% 4.58M -68.04% 13.65M 11.51% 39.9M
-Short-term investments
-22.97% 16.41M 32.74% 32.19M 53.30% 36.72M -26.99% 23.72M
Receivables
5.46% 2.39M 38.84% 2.94M 6.98% 2.11M 49.68% 2.32M
-Accounts receivable
5.46% 2.39M 38.84% 2.94M 6.98% 2.11M 49.68% 2.32M
Inventory
-44.60% 5.39M -44.59% 5.3M -43.74% 5.51M -45.02% 5.07M
Prepaid assets
14.42% 1.12M -14.94% 1.43M -19.51% 1.52M -34.47% 768K
Other current assets
30.47% 1.97M 8.08% 1.62M 7.78% 1.59M -12.47% 1.56M
Total current assets
-7.33% 66.27M -42.58% 48.06M -25.30% 61.11M -10.56% 73.33M
Non current assets
Net PPE
1.66% 7.95M 5.00% 8.82M -15.59% 7.46M -15.23% 7.9M
-Gross PPE
-0.23% 18.77M 0.51% 19.82M -7.44% 18.34M -7.22% 18.7M
-Accumulated depreciation
1.58% -10.82M 2.83% -11M 0.89% -10.88M 0.33% -10.8M
Other non current assets
-10.97% 1.62M -2.48% 1.85M -11.56% 1.79M -14.29% 1.82M
Total non current assets
-0.73% 9.58M 3.62% 10.67M -14.84% 9.25M -15.06% 9.72M
Total assets
-6.55% 75.85M -37.52% 58.73M -24.08% 70.36M -11.11% 83.05M
Liabilities
Current liabilities
Payables
20.99% 2.82M 18.33% 2.22M 41.73% 2.72M 53.72% 1.98M
-accounts payable
20.99% 2.82M 18.33% 2.22M 41.73% 2.72M 53.72% 1.98M
Current accrued expenses
18.92% 4.42M 25.64% 6.4M 24.33% 4.24M -11.54% 3.76M
Current debt and capital lease obligation
81.24% 1.81M -14.29% 1.77M -48.93% 857K -28.67% 749K
-Current debt
-77.27% 80K -94.21% 84K -92.72% 82K -85.53% 80K
-Current capital lease obligation
167.75% 1.73M 175.33% 1.69M 40.65% 775K 34.61% 669K
Current deferred liabilities
11.73% 524K 18.79% 335K 11.48% 398K 19.95% 451K
Current liabilities
27.39% 9.57M 15.11% 10.73M 11.54% 8.21M -0.34% 6.95M
Non current liabilities
Long term debt and capital lease obligation
-33.38% 75.1M -29.01% 109.21M -21.89% 118.11M -25.90% 110.37M
-Long term debt
-34.07% 72.62M -29.96% 105.83M -21.95% 115.76M -25.97% 107.98M
-Long term capital lease obligation
-3.74% 2.47M 23.04% 3.38M -18.76% 2.36M -22.27% 2.38M
Non current accrued expenses
-- 220K -- -- -- -- -- --
Other non current liabilities
11.95% 759K 30.52% 757K 77.70% 805K 141.19% 808K
Total non current liabilities
-32.91% 76.08M -28.79% 109.97M -21.59% 118.92M -25.52% 111.17M
Total liabilities
-29.17% 85.64M -26.29% 120.69M -20.06% 127.13M -24.40% 118.12M
Shareholders'equity
Share capital
48.53% 101K 37.70% 84K 21.67% 73K 24.14% 72K
-common stock
49.23% 97K 31.15% 80K 15.00% 69K 17.24% 68K
-Preferred stock
33.33% 4K -- 4K -- 4K -- 4K
Retained earnings
-8.14% -592.44M -7.02% -576.73M -8.07% -558.93M -15.76% -570.67M
Paid-in capital
13.51% 627.85M 8.96% 560.19M 10.39% 547.38M 22.22% 580.65M
Less: Treasury stock
0.00% 45.07M 0.00% 45.07M 0.00% 45.07M 0.00% 45.07M
Gains losses not affecting retained earnings
-1,341.18% -245K -3,423.08% -432K -2,477.78% -232K -165.93% -60K
Total stockholders'equity
75.35% -9.8M 11.16% -61.96M 14.45% -56.78M 44.17% -35.07M
Total equity
75.35% -9.8M 11.16% -61.96M 14.45% -56.78M 44.17% -35.07M
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
CEO: Mr. John Phillips
Market: NASDAQ
Listing Date: 12/26/2012
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist